Showing 381 - 400 results of 225,503 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 10 ((nm decrease) OR (a decrease)) ))', query time: 0.99s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384
  5. 385
  6. 386
  7. 387
  8. 388
  9. 389

    Knockdown of FZD10 results in a decrease in cell proliferation in the neural tube. by Abdulmajeed Fahad Alrefaei (8968607)

    Published 2020
    “…(F) Quantification of the number of pH3 positive cells per section in the neural tube electroporated with FZD10 shRNA vector compared to the non-electroporated side showed that there was a statistically significant decrease in the number of pH3 positive cells (students t-test (paired)).…”
  10. 390
  11. 391
  12. 392
  13. 393
  14. 394

    DataSheet_1_Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat.pdf by Marta Díaz (337207)

    Published 2023
    “…Circulating exosomes of SGAs (as compared to those of AGAs) had a larger size at birth [146.8 vs 137.8 nm, respectively; p=0.02], and were in lower number at ages 2 [4.3x10<sup>11</sup>vs 5.6x10<sup>11</sup> particles/mL, respectively; p=0.01] and 7 [6.3x10<sup>11</sup>vs 6.8x10<sup>11</sup> particles/mL, respectively; p=0.006]. …”
  15. 395
  16. 396
  17. 397

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  18. 398

    Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... by Shuai Wang (109515)

    Published 2021
    “…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …”
  19. 399
  20. 400